KIMS vs MEDANTA: Stock Comparison

KRISHNA INST OF MED SCI L vs GLOBAL HEALTHUpdated 11 Sept 26, 4:08 PM ISTNSE & company filings

GLOBAL HEALTH is the larger company by market capitalisation. KRISHNA INST OF MED SCI L shows faster revenue growth, while GLOBAL HEALTH shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

KIMS leads 2; MEDANTA leads 11 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

KIMSMEDANTA

Valuation lens

What price are you paying?

Market CapContext only
₹32,208 Cr
₹38,774 Cr
P/E RatioMEDANTA has the lower reading
151.55x
69.7x
P/B RatioMEDANTA has the lower reading
13.65x
9.78x
EPSMEDANTA has the higher reading
₹0.99
₹5.9
Book ValueContext only
₹60.92
₹148.18
Dividend YieldMEDANTA has the higher reading
0%
0.03%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
MEDANTA is the larger company
₹38,774 Cr vs ₹32,208 Cr
P/E Ratio
MEDANTA has a lower P/E
69.7x vs 151.55x
P/B Ratio
MEDANTA has a lower P/B
9.78x vs 13.65x
EPS
MEDANTA has higher earnings per share
₹5.9 vs ₹0.99
Dividend Yield
MEDANTA has a higher dividend yield
0.03% vs 0%
Revenue Growth (TTM YoY)
KIMS has faster revenue growth
34.8% vs 24.5%
EPS Growth (TTM YoY)
MEDANTA has faster EPS growth
42% vs -58.3%
Qtr Sales Growth
KIMS has stronger quarterly sales growth
143.9% vs 20.89%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricKIMSMEDANTA
SectorHealthcareHealthcare
IndustryHospitalHospital

Price

MetricKIMSMEDANTA
Live Price₹768.95₹1,447.2
Day Change-0.5%-0.85%
Volume1.28 L74,678
52-Week High₹858₹1,544
52-Week Low₹575.8₹956
Distance from 52W High-10.38%-6.27%

Valuation

MetricKIMSMEDANTA
Market Cap₹32,208 Cr₹38,774 Cr
P/E Ratio151.55x69.7x
P/B Ratio13.65x9.78x
EPS₹0.99₹5.9
Book Value₹60.92₹148.18
Dividend Yield0%0.03%

Growth

MetricKIMSMEDANTA
Revenue Growth (TTM YoY)34.8%24.5%
EPS Growth (TTM YoY)-58.3%42%
Qtr Sales Growth143.9%20.89%
Qtr Profit Growth-43.76%14.53%

Profitability & Leverage

MetricKIMSMEDANTA
ROE9.46%12.37%
ROCE5.43%11.4%
Net Margin6.18%12.62%
Operating Margin13.67%18.62%
Debt to Equity1.27x0.17x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricKIMSMEDANTA
Promoter Holding32.5% 1.61 pp33% 0.01 pp
FII Holding14.74% 0.17 pp9.46% 0.69 pp
DII Holding34.43% 1.93 pp16.89% 2.13 pp
Public Holding18.33% 0.49 pp40.56% 1.44 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: KRISHNA INST OF MED SCI L and GLOBAL HEALTH.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.